Table 1.

Formulations components (concentrations are presented as gram unit) and their particle size and entrapment efficiency (EE%) (Mean ± SD, n = 5).

Batch No.	Chol	Leci	O.A	Polox	Lab + las (CMC)	PG	PEG	Cipro	R-g3	EE%	Particle Size (nm)
1	0.135	0.45	0.06	0.2	(3 CMC)	2	0.7	0.01	0.01	43.7 ± 5.7	137 ± 4.5
2	0.135	0.45	0.06	0.2	(3 CMC)	2	0.7	0.025	0.02	73.5 ± 6.6	121 ± 8.2
3	0.135	0.45	0.06	0.2	(3 CMC)	2	0.7	0.01	0.02	82.8 ± 5.8	120 ± 10.9
4	0.135	0.45	0.06	0.2	(3 CMC)	2	0.7	0.025	0.01	87.9 ± 7.3	127 ± 14.3
5	0.135	0.45	0.06	0.2	(1 CMC)	2	0.7	0.01	0.01	33.7 ± 3.7	183 ± 12.5
6	0.135	0.45	0.06	0.2	(1 CMC)	2	0.7	0.025	0.02	39.5 ± 4.2	126 ± 13.1
7	0.135	0.45	0.06	0.2	(1 CMC)	2	0.7	0.01	0.02	27.9 ± 3.1	109 ± 7.2
8	0.135	0.45	0.06	0.2	(1 CMC)	2	0.7	0.025	0.01	30.4 ± 2.4	153 ± 9.9

Chol: cholesterol; Leci: Lecithin; Polox: Poloxamer; Lab + Las: Labrafil + Labrasol; PG: propylene glycol; PEG: Polyethylene glycol; Cipro: Ciprofloxacin; R-g3: R-g3 Ginsenoside; EE%: entrapment efficiency.